CIK 0001861107 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Ceribell, Inc.
Sign in to watch- Ticker
- CBLL
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471785452
- Phone
- (800) 436-0826
- Business address
- 360 N. PASTORIA AVENUE, SUNNYVALE, CA, 94085
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,895,466
- in 17 filings, $4.4M under 10b5-1 plans
Net −$4,895,466. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 16 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-08 | Foehr David Senior VP, Finance and PAO | Sale 10b5-1 | −1,755 | $24.26 | $43K | 34,144 |
| 2026-09-08 | Foehr David Senior VP, Finance and PAO | Option exercise 10b5-1 | +7,500 | $4.70 | $35K | 41,644 |
| 2026-09-08 | Foehr David Senior VP, Finance and PAO | Sale 10b5-1 | −7,500 | $24.25 | $182K | 34,144 |
| 2026-09-08 | Foehr David Senior VP, Finance and PAO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,500 | 45,385 | ||
| 2026-08-24 | Foehr David Senior VP, Finance and PAO | Sale 10b5-1 | −859 | $23.95 | $21K | 35,899 |
| 2026-08-21 | Foehr David Senior VP, Finance and PAO | Sale 10b5-1 | −993 | $24.02 | $24K | 36,758 |
| 2026-05-22 | Foehr David Senior VP, Finance and PAO | Sale 10b5-1 | −862 | $18.80 | $16K | 37,751 |
| 2026-05-21 | Foehr David Senior VP, Finance and PAO | Sale 10b5-1 | −987 | $18.00 | $18K | 38,613 |
| 2026-04-01 | Foehr David Senior VP, Finance and PAO | Grant or award | +22,050 | 39,600 | ||
| 2026-04-01 | Foehr David Senior VP, Finance and PAO | Grant or award · Stock Option (Right to Buy) | +36,750 | 36,750 | ||
| 2026-03-03 | Foehr David Senior VP, Finance and PAO | Option exercise 10b5-1 | +3,403 | $4.70 | $16K | 20,953 |
| 2026-03-03 | Foehr David Senior VP, Finance and PAO | Sale 10b5-1 | −3,403 | $17.80 | $61K | 17,550 |
| 2026-03-03 | Foehr David Senior VP, Finance and PAO | Option exercise 10b5-1 | +1,157 | $4.70 | $5K | 18,707 |
| 2026-03-03 | Foehr David Senior VP, Finance and PAO | Sale 10b5-1 | −1,157 | $17.80 | $21K | 17,550 |
| 2026-03-03 | Foehr David Senior VP, Finance and PAO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,403 | 54,042 | ||
| 2026-03-03 | Foehr David Senior VP, Finance and PAO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,157 | 52,885 | ||
| 2026-02-24 | Foehr David Senior VP, Finance and PAO | Sale 10b5-1 | −781 | $19.98 | $16K | 17,550 |
| 2026-02-23 | Foehr David Senior VP, Finance and PAO | Sale 10b5-1 | −569 | $19.79 | $11K | 18,331 |
| 2026-02-03 | Foehr David Senior VP, Finance and PAO | Option exercise 10b5-1 | +3,403 | $4.70 | $16K | 22,303 |
| 2026-02-03 | Foehr David Senior VP, Finance and PAO | Sale 10b5-1 | −3,403 | $20.00 | $68K | 18,900 |
Page 1 of 2 · 40 trades